Novavax COVID-19 vaccine (Nuvaxovid, CovoVax, NVX-CoV2373, TAK-019) (SARS-CoV-2 rS [Recombinant, adjuvanted)) is a protein-based vaccine candidate engineered from the genetic sequence of the first strain of the SARS-CoV-2 beta coronavirus. The vaccine was created using Novavax's proprietary nanoparticle technology, Matrix-M, an adjuvant to enhance immune responses and stimulate high levels of neutralizing antibodies.


if you don't know what that means,

ask,

i can tell you